Vnitr Lek 2022, 68(2):82-84 | DOI: 10.36290/vnl.2022.016

Prediabetes

Hana Rosolová
Centrum preventivní kardiologie LF UK v Plzni, 2. interní klinika FN Plzeň

Prediabetes is defined as impaired fasting glucose or impaired glucose tolerance. It often appears as a part of metabolic syndrome and then represents high cardiometabolic risk. The cornestones of prediabetes management and Type 2 diabetes and cardiovascular disease prevention are weight reduction and regular physical activity. Suitable drugs for prediabetic patients are mentioned.

Keywords: prediabetes, metabolic syndrome, type 2 diabetes prevention, atherosclerotic cardiovascular disease prevention, healthy life style.

Published: April 4, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rosolová H. Prediabetes. Vnitr Lek. 2022;68(2):82-84. doi: 10.36290/vnl.2022.016.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Perušičová J, Pelikánová T, Škrha M et al. za výbor ČDS. Doporučený postup péče o nemocné s prediabetem. DMEV 2012;15:20-22.
    2. Diabetes Canada Clinical Practice Guidelines Expert Committee: Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2018;42:S10-S15. Go to original source... Go to PubMed...
    3. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: A joint interim statement of the IDF Task Force on Epidemiology and Prevention; NHLBI, AHA, WHF, IAS, IASO. Circulation 2009;120:1640-1645. Go to original source... Go to PubMed...
    4. Huang Y, Cai X, Mai W et al. Association between prediabates and risk of cardiovascular disease and all cause mortality. Systematic review and metaanalysis. BMJ 2016;355:i5953. Go to original source... Go to PubMed...
    5. Warren B, Pankow JS, Matsushita K et al. Comparative prognostic performance of definitions of prediabetes. A prospective cohort analysis of the ARIC study. Lancet Diabetes Endocrinol. 2016;5:34-42. Go to original source... Go to PubMed...
    6. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344:1343-1350. Go to original source... Go to PubMed...
    7. Knowler WC, Fowler SE, Hamman RF et al. 10-year follow‑up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374:1677-1686. Go to original source... Go to PubMed...
    8. Hamman RF, Wing RR, Edelstein SL et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006; 29:2102-2107. Go to original source... Go to PubMed...
    9. Visseren FLJ, Mach F, Smulders YM et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. EHJ 2021; doi:10.1093/eurheartj/ehab484. Go to original source... Go to PubMed...
    10. Thomson EM: Air Pollution, Stress, and Allostatic Load: Linking Systemic and Central Nervous System Impacts. Journal of Alzheimer's Disease. 69 (2019) 597-614. Go to original source... Go to PubMed...
    11. Lilly M, Godwin M. Treating prediabetes with metformin: systematic review and meta‑analysis. Can Fam Physician. 2009;55:363-369. Go to PubMed...
    12. DeFronzo RA, Tripathy D, Schwenke DC et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104-1115. Go to original source... Go to PubMed...
    13. Coulter AA, Rebello CJ, Greenway FL. Centrally Acting Agents for Obesity: Past, Present, and Future. Drugs. 2018 Jul;78(11):1113-1132. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.